(October 24, 2023, 12:31 PM EDT) -- BOSTON — A panel of the First Circuit U.S. Court of Appeals partly reversed a federal judge’s dismissal of a complaint brought by a group of investors who claimed that a pharmaceutical manufacturer and certain of its executives concealed data about an Alzheimer’s disease drug’s clinical trials, finding that the investors adequately alleged scienter regarding a single claim allegedly made by one of the executives....